Gentarget
Latest round
- Series A
Last raised
- Oct 2015
Total raised
- Undisclosed
Investors
- 3
About Gentarget
Established in 2015 and based in Shenzhen, China, Gentarget is a medicine developer that focuses on the development and clinical application of biological drugs. The company specializes in the development and clinical translation of viral, non-viral modifications and CRISPR/Cas9 gene editing. It also focuses on the development of First-in-Class biologics to provide drug solutions for multiple major diseases, including malignant tumors, cardiovascular and cerebrovascular diseases, degenerative diseases, and autoimmune diseases.
Who invested in Gentarget
3 investors across 1 round
See all investors in Gentarget
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 19, 2015
Amount
Undisclosed
Investors
Questions about Gentarget
Who invested in Gentarget?
Gentarget has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Gentarget raised?
Gentarget has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Gentarget last raise money?
Gentarget's most recent round on record is a Series A, in Oct 2015.
What does Gentarget do?
Established in 2015 and based in Shenzhen, China, Gentarget is a medicine developer that focuses on the development and clinical application of biological drugs.
Where is Gentarget headquartered?
Gentarget is headquartered in Shenzhen, China.
Which VCs invest in companies like Gentarget?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Gentarget's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Gentarget? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.